Even UBS has reduced its evaluation with publication from May 9, 2024 from 1 A$ to $ 0.8 A$. Why do they lower their evaluation? Because not all prospects are as outstanding as some always tell here.
- Forums
- ASX - By Stock
- SYR Charts
Even UBS has reduced its evaluation with publication from May 9,...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.5¢ |
Change
-0.035(8.14%) |
Mkt cap ! $408.7M |
Open | High | Low | Value | Volume |
43.0¢ | 43.0¢ | 39.0¢ | $2.924M | 7.122M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14703 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 67106 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14703 | 0.395 |
7 | 478681 | 0.390 |
7 | 588216 | 0.385 |
13 | 564846 | 0.380 |
3 | 306850 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 67106 | 2 |
0.415 | 5000 | 1 |
0.420 | 337780 | 16 |
0.425 | 107000 | 5 |
0.430 | 79717 | 4 |
Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
40.0¢ |
  |
Change
-0.035 ( 7.04 %) |
|||
Open | High | Low | Volume | ||
42.8¢ | 42.8¢ | 39.0¢ | 1775020 | ||
Last updated 15.59pm 12/06/2024 ? |
Featured News
SYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online